Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
2013
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
2015 Standout
Acromegaly
2006 Standout
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
2020
Idiopathic pulmonary fibrosis
2017 Standout
Body mass index in relation to semen quality and reproductive hormonesamong 1,558 Danish men
2004 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Glycosaminoglycans: key players in cancer cell biology and treatment
2012
Targeting ECM Disrupts Cancer Progression
2015
The tumor microenvironment
2020 Standout
Versican and the regulation of cell phenotype in disease
2014
Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation
2005 StandoutNobel
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Retinoblastoma protein partners
2001
Extracellular matrix structure
2015 Standout
Sex hormone-binding globulin as a marker for hyperinsulinemia and/or insulin resistance in obese children
2000
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase varepsilon
2000
Hyaluronan: A modulator of the tumor microenvironment
2016
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine
2015
Determinants of clinical outcome and survival in acromegaly
1994
LOX-1 and Angiotensin Receptors, and Their Interplay
2011
Gender and age influence the relationship between serum GH and IGF‐I in patients with acromegaly
2002
Natural products as lead compounds in drug discovery
2013
Long-Term Follow-Up Results of Postoperative Radiotherapy in 36 Patients with Acromegaly
2000
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
Acromegaly—Consensus, What Consensus?
2002
Marine natural products
2015 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Basal, But Not Pulsatile, Growth Hormone Secretion Determines the Ambient Circulating Levels of Insulin-Like Growth Factor-I
2010
LOX-1, OxLDL, and Atherosclerosis
2013 Standout
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone
1994
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Diagnostic Value of the Acid-Labile Subunit in Acromegaly: Evaluation in Comparison with Insulin-Like Growth Factor (IGF) I, and IGF-Binding Protein-1, -2, and -31
2001
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
2004 StandoutNobel
Works of Junji Wasa being referenced
Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo
2011
Inhibition of hyaluronan synthesis in breast cancer cells by 4‐methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo
2011
Versican V1 isoform regulates cell‐associated matrix formation and cell behavior differentially from aggrecan in Swarm rat chondrosarcoma cells
2011
Phosphorylated retinoblastoma protein stimulates DNA polymerase α
1997
Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer
2011
Inter‐relations between growth hormone, insulin, insulin‐like growth factor‐l (IGF‐I), IGF‐binding protein‐1 (IGFBP‐1) and sex hormone‐binding globulin in acromegaly
1991
The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model.
2011